A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study)

Small Cell ◽

Small Cell Lung ◽

Multicenter Phase ◽

Reverse Sequence ◽

Vulnerable Elderly

A multicenter phase II randomized study of gemcitabine (G) weekly followed by erlotinib (E) after progression versus E followed by G after progression in advanced non-small cell lung cancer (NSCLC) in vulnerable elderly patients selected with a comprehensive geriatric assessment (CGA) (GFPC*0505).

10.1200/jco.2010.28.15_suppl.e18002 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e18002-e18002

Author(s):

H. Jullian ◽

L. Greillier ◽

C. Chouaid ◽

R. Corre ◽

J. Crequit ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Randomized Study ◽

Small Cell ◽

Small Cell Lung ◽

Multicenter Phase ◽

Vulnerable Elderly

A multicenter phase II randomized study of docetaxel (D)/gemcitabine (G) weekly followed by erlotinib (E) after progression versus erlotinib followed by docetaxel/gemcitabine after progression in advanced non-small cell lung cancer (NSCLC) in fit elderly patients selected with a comprehensive geriatric assessment (CGA): Groupe Français de Pneumocancerologie (GFPC)*0504.

10.1200/jco.2010.28.15_suppl.7536 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7536-7536

Author(s):

H. Le Caer ◽

F. Barlesi ◽

R. Corre ◽

H. Jullian ◽

S. Bota ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Phase Ii ◽

Randomized Study ◽

Small Cell ◽

Small Cell Lung ◽

Multicenter Phase

P66 A multicenter phase II randomized study of docetaxel/gemcitabine weekly followed by erlotinib after progression versus erlotinib followed by docetaxel/gemcitabine after progression in advanced non small cell lung cancer (NSCLC) in fit elderly patients selected with a comprehensive geriatric assessment (CGA) (gfpc*0504): preliminary results

Critical Reviews in Oncology/Hematology ◽

10.1016/s1040-8428(09)70104-0 ◽

2009 ◽

Vol 72 (1) ◽

pp. S42

Author(s):

H. Le Caer ◽

F. Barlesi ◽

R. Corre ◽

H. Jullian ◽

D. Balas ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Phase Ii ◽

Randomized Study ◽

Small Cell ◽

Small Cell Lung ◽

Multicenter Phase

A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study)

British Journal of Cancer ◽

10.1038/bjc.2011.331 ◽

2011 ◽

Vol 105 (8) ◽

pp. 1123-1130 ◽

Cited By ~ 16

Author(s):

H LeCaer ◽

◽

F Barlesi ◽

R Corre ◽

H Jullian ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Randomised Trial ◽

Small Cell ◽

Small Cell Lung ◽

Multicentre Phase ◽

Weekly Docetaxel ◽

Reverse Sequence

Faculty Opinions recommendation of Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726151262.793518485 ◽

2016 ◽

Author(s):

Maria-José Molina-Garrido

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Geriatric Assessment ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung

O-088 Phase III randomized trial comparing weekly vs. standard schedules of paclitaxel (P) plus carboplatin (C) for advanced non-small cell lung cancer (NSCLC): Analyses of elderly patients

Lung Cancer ◽

10.1016/s0169-5002(05)80222-3 ◽

2005 ◽

Vol 49 ◽

pp. S32 ◽

Cited By ~ 3

Author(s):

C. Belani ◽

S. Ramalingam ◽

M. Perry ◽

R. LaRocca ◽

D. Rinaldi ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Randomized Trial ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung

First Line Chemotherapy with Weekly Docetaxel and Cisplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer: A Multicenter Phase II Study

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181991d38 ◽

2009 ◽

Vol 4 (4) ◽

pp. 512-517 ◽

Cited By ~ 3

Author(s):

Keqi Han ◽

Weiguo Cao ◽

Jinfeng Che ◽

Shenxu Bo ◽

Xiaodong Guo ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Weekly Docetaxel ◽

Multicenter Phase ◽

Line Chemotherapy

Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the “polmone toscano group” (POLTO)

Lung Cancer ◽

10.1016/j.lungcan.2004.10.008 ◽

2005 ◽

Vol 48 (1) ◽

pp. 121-127 ◽

Cited By ~ 8

Author(s):

C. Tibaldi ◽

S. Ricci ◽

F. Russo ◽

I. Bernardini ◽

L. Galli ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Dose Intensity ◽

Small Cell ◽

Small Cell Lung ◽

Multicenter Phase

Multicenter phase II study of the combination of carboplatin and paclitaxel as first line treatment in elderly patients with advanced non small cell lung cancer (NSCLC)

10.1200/jco.2004.22.14_suppl.7239 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7239-7239 ◽

Cited By ~ 4

Author(s):

I. Okamoto ◽

E. Moriyama ◽

H. Kishi ◽

M. Nomura ◽

F. Imamura ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Multicenter Phase ◽

First Line Treatment

Outcome of elderly (≥70 years) non-small cell lung cancer (NSCLC) patients on a multicenter, phase III randomized trial comparing weekly vs. standard schedules of paclitaxel (P) plus carboplatin (C)

10.1200/jco.2005.23.16_suppl.7149 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7149-7149 ◽

Cited By ~ 1

Author(s):

S. Ramalingam ◽

M. C. Perry ◽

R. V. Larocca ◽

D. A. Rinaldi ◽

P. Gable ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Trial ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Multicenter Phase ◽

Nsclc Patients